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Abstract 
Estrogen deficiency results in disruption of the normal bone remodeling cycle leading to a 
loss of bone mineral and, in many cases, the development of osteoporosis. Various studies 
have demonstrated a beneficial effect of essential fatty acids (EF As) in reducing the loss of 
bone density as a consequence of estrogen deficiency. The aim of the present study was to 
examine the specific effects of the n-3 EF A, eicosopentaenoic acid (EPA) on bone density 
and strength in ovariectomised female rats. 
60 Sprague-Dawley rats were randomized into four groups and either ovariectomised 
(n=45) or sham operated (n=l5). Ovariectomised animals were fed calcium adequate diets 
containing either com oil (OVX control, n=l5), com oil+ O.lg/kg body weight EPA (low 
dose, n=15) or com oil+ l.Og/kg body weight EPA (high dose, n=15) for a period of nine 
weeks. Sham rats were fed the corn oil diet as per the OVX control group. Urinary calcium 
and phosphate excretion, serum type 1 collagen c-telopeptide concentration, bone density, 
bone ash and bone breaking strength were measured. Plasma fatty acid composition and 
serum concentrations of 25 hydroxyvitamin D3 were also determined. 
Femur bone density was significantly lower in the high dose group compared to sham, 
OVX control and low dose EPA groups (p<0.001, p=0.0096 and p=0.0047 respectively). 
Low dose EPA supplementation had no significant effect on bone density. No significant 
differences in urinary calcium or phosphate concentrations, serum concentrations of type- I 
collagen c-telopeptide or bone breaking strength were evident with either dose of EPA 
compared to unsupplemented, ovariectomised controls. EPA supplementation resulted in 
significant decreases in the levels of n-6 EF As and increases in the levels of n-3 EF As 
except docosahexaenoic acid in plasma lipids. Both low and high dose EPA 
supplementation led to significant increases in serum concentration of 25(0H) vitamin D3. 
In conclusion l .Og EPA/kg body weight had a detrimental effect on bone density in 
ovariectomised rats. It is proposed that high intake of the highly unsaturated EPA resulted 
in significant lipid peroxidation. This in turn disrupted membrane structure aQd inhibited 
. '· 
intestinal calcium absorption thereby stimulating PTH-mediated bone resorption. A 
potential role for n-3 EFAs in the regulation of vitamin D activity is also outlined. 
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